{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:22:07Z","timestamp":1780683727128,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["091625"],"award-info":[{"award-number":["091625"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (AU)","doi-asserted-by":"publisher","award":["1023438"],"award-info":[{"award-number":["1023438"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (AU)","doi-asserted-by":"publisher","award":["1035261"],"award-info":[{"award-number":["1035261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (AU)","doi-asserted-by":"publisher","award":["1023438"],"award-info":[{"award-number":["1023438"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (AU)","doi-asserted-by":"publisher","award":["1035261"],"award-info":[{"award-number":["1035261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1173-1","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T07:20:33Z","timestamp":1456903233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms"],"prefix":"10.1186","volume":"15","author":[{"given":"Grennady","family":"Wirjanata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Handayuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie G.","family":"Zaloumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferryanto","family":"Chalfein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak","family":"Prayoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enny","family":"Kenangalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Rini","family":"Poespoprodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintis","family":"Noviyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Marfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"1173_CR1","first-page":"2014","volume-title":"Geneva","author":"WHO. World Malaria Report","year":"2014","unstructured":"WHO. World Malaria Report. Geneva. Switzerland: World Health Organization; 2014. p. 2014."},{"key":"1173_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4922(03)00028-X","volume":"19","author":"H Noedl","year":"2003","unstructured":"Noedl H, Wongsrichanalai C, Wernsdorfer WH. Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 2003;19:175\u201381.","journal-title":"Trends Parasitol"},{"key":"1173_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4269\/ajtmh.2007.77.160","volume":"77","author":"MK Laufer","year":"2007","unstructured":"Laufer MK, Djimd\u00e9 AA, Plowe CV. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Am J Trop Med Hyg. 2007;77:160\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1173_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1475-2875-6-120","volume":"6","author":"DJ Bacon","year":"2007","unstructured":"Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichanalai C, Fukuda MM, et al. World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J. 2007;6:120.","journal-title":"Malar J"},{"key":"1173_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4269\/ajtmh.2003.69.168","volume":"69","author":"LK Basco","year":"2003","unstructured":"Basco LK. Molecular epidemiology of malaria in Cameroon. XV. Experimental studies on serum substitutes and supplements and alternative culture media for in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2003;69:168\u201373.","journal-title":"Am J Trop Med Hyg"},{"key":"1173_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4269\/ajtmh.2004.70.474","volume":"70","author":"LK Basco","year":"2004","unstructured":"Basco LK. Molecular epidemiology of malaria in Cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2004;70:474\u201380.","journal-title":"Am J Trop Med Hyg"},{"key":"1173_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","volume":"10","author":"JL Sebaugh","year":"2011","unstructured":"Sebaugh JL. Guidelines for accurate EC50\/IC50 estimation. Pharm Stat. 2011;10:128\u201334.","journal-title":"Pharm Stat"},{"key":"1173_CR8","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","volume":"49","author":"H Noedl","year":"2005","unstructured":"Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005;49:3575.","journal-title":"Antimicrob Agents Chemother"},{"key":"1173_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cmpb.2010.08.003","volume":"104","author":"H Nagard Le","year":"2011","unstructured":"Le Nagard H, Vincent C, Mentr\u00e9 F, Le Bras J. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed. 2011;104:10\u20138.","journal-title":"Comput Methods Programs Biomed"},{"key":"1173_CR10","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/AAC.02350-12","volume":"7","author":"CJ Woodrow","year":"2013","unstructured":"Woodrow CJ, Dahlstr\u00f6m S, Cooksey R, Flegg JA, Le Nagard H, Mentr\u00e9 F, et al. High-throughput analysis of antimalarial susceptibility data by the WWARN In Vitro Analysis and Reporting Tool (IVART). Antimicrob Agents Chemother. 2013;7:3121\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"1173_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4269\/ajtmh.2001.64.233","volume":"64","author":"P Druilhe","year":"2001","unstructured":"Druilhe P, Moreno A, Blanc C, Brasseur PH, Jacquier P. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2001;64:233\u201341.","journal-title":"Am J Trop Med Hyg"},{"key":"1173_CR12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01334-07","volume":"52","author":"B Russell","year":"2008","unstructured":"Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, et al. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother. 2008;52:1040\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1173_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","volume":"369","author":"A Ratcliff","year":"2007","unstructured":"Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007;369:757\u201365.","journal-title":"Lancet"},{"key":"1173_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1475-2875-7-148","volume":"7","author":"M Karyana","year":"2008","unstructured":"Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008;7:148.","journal-title":"Malar J"},{"key":"1173_CR15","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/AAC.00283-12","volume":"56","author":"J Marfurt","year":"2012","unstructured":"Marfurt J, Chalfein F, Prayoga P, Wabiser F, Wirjanata G, Sebayang B, et al. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant Plasmodium falciparum and P. vivax. Antimicrob Agents Chemother. 2012;56:5258\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"1173_CR16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1475-2875-9-375","volume":"9","author":"C Lourens","year":"2010","unstructured":"Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, et al. Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J. 2010;9:375.","journal-title":"Malar J"},{"key":"1173_CR17","unstructured":"\u201cAmbiguous\u201d [ http:\/\/www.graphpad.com\/guides\/prism\/6\/curve-fitting\/index.htm?reg_example_ambiguous_fit.htm ]."},{"key":"1173_CR18","unstructured":"HN-NonLin Nonlinear Evaluation of Malaria Drug Sensitivity Data [ http:\/\/www.meduniwien.ac.at\/user\/harald.noedl\/malaria\/software.html ]."},{"key":"1173_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1096\/fasebj.1.5.3315805","volume":"1","author":"HJ Motulsky","year":"1987","unstructured":"Motulsky HJ, Ransnas LA. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1987;1:365\u201374.","journal-title":"FASEB J"},{"key":"1173_CR20","unstructured":"Choosing a Model [ http:\/\/www.meduniwien.ac.at\/user\/harald.noedl\/malaria\/help01b.html ]."},{"key":"1173_CR21","unstructured":"Run Regression [ http:\/\/www.antimalarial-icestimator.net\/runregression1.2.htm ]."},{"key":"1173_CR22","unstructured":"IVART Online Step-by-step User guide [ http:\/\/www.wwarn.org\/sites\/default\/files\/IVARTstep-by-step.pdf ]."},{"key":"1173_CR23","unstructured":"IVART [ http:\/\/www.wwarn.org\/tools-resources\/toolkit\/analyse\/ivart ]."},{"key":"1173_CR24","doi-asserted-by":"crossref","first-page":"e69505","DOI":"10.1371\/journal.pone.0069505","volume":"8","author":"JA Simpson","year":"2013","unstructured":"Simpson JA, Jamsen KM, Anderson TJ, Zaloumis S, Nair S, Woodrow C, et al. Nonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparum. PLoS ONE. 2013;8:e69505.","journal-title":"PLoS ONE"},{"key":"1173_CR25","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51:1926\u201333.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1173-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T01:17:39Z","timestamp":1567646259000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/15\/1\/137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1173-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]},"article-number":"137"}}